Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalon...
Enregistré dans:
Auteurs principaux: | Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli, Marc Miravitlles |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
par: Alexa Núñez, et autres
Publié: (2021) -
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
par: Sandeep Bansal, et autres
Publié: (2021) -
Mepolizumab and COPD in Real Life
par: Fernando Revuelta-Salgado, et autres
Publié: (2022) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
par: Jafar Aljazeeri, et autres
Publié: (2021) -
Towards precision in defining COPD exacerbations
par: Christine R. Jenkins
Publié: (2021)